Skip to main content

Earnings boost: Route Mobile shares spike 25% in three days to hit record high

In the half year ended September 2020, its profit more than doubled to Rs 60 crore compared to Rs 26 crore YoY and revenue grew by 54.5 percent to Rs 658.9 crore YoY.

Route Mobile shares have rallied 24.5 percent in three consecutive sessions and have touched a record high of Rs 990 on October 29 boosted by robust earnings performance.

The stock has given multibagger return of 180 percent from its issue price of Rs 350 per share, to all IPO investors, if they still hold allotted shares. It listed with 105 percent premium on September 21.

The cloud communication platform provider has reported a whopping 158 percent year-on-year growth in Q2FY21 profit at Rs 32.9 crore and registered a 77.7 percent YoY rise in revenue at Rs 349.3 crore in the quarter.



"Q2FY21 has been another quarter of strong performance, backed by better operating leverage, despite the trying circumstances. The pandemic has accelerated CPaaS adoption amongst enterprises, and Route Mobile continues to enable our customers in their digital communication journey," Rajdipkumar Gupta, Managing Director & Group Chief Executive Officer said.

As per Gartner estimates, by 2023, 90 percent of Global enterprises will leverage AP/ enabled CPaaS offerings to enhance their digital competitiveness, up from 20 percent in 2020. "We are optimally positioned to be at the forefront and drive this transformation," Gupta said.

At the operating level, earnings before interest, tax, depreciation and amortisation (EBITDA) in Q2 shot up 143.6 percent to Rs 41.9 crore and margin expanded 330 bps to 12 percent compared to year-ago period, driven by operating leverage.

In the half year ended September 2020, its profit more than doubled to Rs 60 crore compared to Rs 26 crore YoY and revenue grew by 54.5 percent to Rs 658.9 crore YoY.

"Route Mobile witnessed positive momentum in revenues through the past 6 months (period ended September 2020)," said the company, adding COVID-19 resulted in accelerated adoption of digitisation initiatives by enterprises across the globe, and enterprises implemented significantly larger number of digital communication case studies, leveraging various communication channels.

The company has cash on books at Rs 393.5 crore as of September 2020.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more

Similar to 2020, D-Street is at record high ahead of Budget 2021; will history repeat itself?

  Experts are of the view that a repeat of 2020 or what happened in March might not be possible but some consolidation cannot be ruled out. Back in March when everyone wanted to write-off 2020 from their books, hope and liquidity supported markets and investor sentiment. Nobody thought that after touching a 3-year low in March 2020, benchmark indices would give double-digit returns by the end of the year. The S&P BSE Sensex and Nifty50 rallied by about 15 percent in 2020 and the big outperformance came from the small and midcap stocks. The rally is still continuing in 2021. The S&P BSE Sensex, which climbed Mount 49K, is up over 3 percent while the Nifty50 is up over 4 percent so far in January. Sensex scaling the 49,000-mark and Nifty50 touching 14,500 levels ahead of the Budget 2021 could make anyone cautious about the strength of the rally. Back in January 2020, both Sensex and Nifty touched fresh highs ahead of Budget, and then the market fell like a pack of cards. The ...
Post a Comment
Read more